Back
Day One Biopharmaceuticals, Inc. 10K Form
Sell
49
DAWN
Day One Biopharmaceuticals, Inc.
Last Price:
$8.35
Seasonality Move:
-5.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DAWN News And Ratings
See the #1 stock for the next 7 days that we like better than DAWN
DAWN Financial Statistics
Sales & Book Value
| Annual Sales: | $131.2M |
|---|---|
| Cash Flow: | $-5.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.39 |
| Price / Book: | 1.89 |
Profitability
| EPS (TTM): | -1.48540 |
|---|---|
| Net Income (TTM): | $-151.8M |
| Gross Margin: | $125.9M |
| Return on Equity: | -30.98% |
| Return on Assets: | -27.59% |
Day One Biopharmaceuticals, Inc. Earnings Forecast
Key Day One Biopharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for DAWN is 95.98%.
-
The Selling, General & Administrative Expenses for DAWN have been equal to 88.02% of Gross Profit Margin.
-
The Research & Development expenses have been 173.60% of Revenue.
-
The Net Earning history of DAWN is -72.81% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Day One Biopharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DAWN |
| Website: | dayonebio.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 8.68 |
| Quick Ratio: | 8.29 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DAWN Technical Analysis vs Fundamental Analysis
Sell
49
Day One Biopharmaceuticals, Inc. (DAWN)
is a Sell
Is Day One Biopharmaceuticals, Inc. a Buy or a Sell?
-
Day One Biopharmaceuticals, Inc. stock is rated a SellThe current Day One Biopharmaceuticals, Inc. [DAWN] share price is $8.34. The Score for DAWN is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.